A Million-Person quest to predict disease before it begins
NCT ID NCT07756320
First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time
Summary
This observational study aims to understand how genes and the environment contribute to disease before it is even identified. Researchers will collect biological samples from 100,000 adult Mayo Clinic patients to build a comprehensive data repository. The goal is to predict biological processes that lead to disease, identify ways to stop disease progression early, and find potential targets for future therapies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to new ways to predict and prevent diseases before they become serious, and identify targets for future therapies.
- What could go wrong
- This is an observational study, so it won't test any treatment directly. It may take years to gather enough data, and findings may not lead to immediate medical breakthroughs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXPOSURE, ENVIRONMENTAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nudge in your chart unlock Life-Saving genetic clues?
- Gene mutation may amplify cognitive risks of brain stimulation in Parkinson's
- Could your surroundings trigger a hidden genetic risk?
- Personalized dosing for kids with dystonia? new study investigates genetic factors
- Massive study aims to decode cancer genes for better family counseling
- 12,000-Person study aims to unlock genetic secrets of rare diseases